# Canopy Growth Corporation (CGC) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Pharmaceuticals. Price $0.97, market value $463 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Canopy Growth Corporation reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 2.2×**. Each dollar of revenue is priced at 2.2×.
- **Price / book: 0.8×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **Free-cash-flow yield: -13.0%** (5-yr avg -67.7%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Gross margin: 25.2%**. Canopy Growth Corporation keeps 25.2% of revenue after the direct cost of what it sells.
- **Operating margin: -53.3%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -92.4%**. The company reported a net loss over the last twelve months.
- **Return on equity: -37.7%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -21.8%**. Return on all capital, debt included, is -21.8%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -21.1%**. Each dollar of assets produces -21.1% of profit.

## Growth
- **Revenue growth (1 yr): 5.8%** (3-yr -5.1%/yr, 5-yr -12.2%/yr). Revenue grew 5.8% over the last year, against -12.2% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 81.4%**. Earnings per share rose 81.4%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.33**. Debt is 0.33 times equity: a conservative balance sheet.
- **Altman Z-score: 1.31**. A Z-score of 1.31 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Canopy Growth Corporation does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): -29.5%** (YTD -14.7%, 3-mo -5.6%). The shares are down 29.5% over twelve months including dividends.
- **From 52-week high: -59.1%** (15.2% above the low). Trading 59% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 45**. An RSI of 45 is neutral.
- **Beta (1 yr): 1.53** (volatility 87%). Beta of 1.53 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=CGC · Page: https://foliofundamentals.com/stocks/cgc

Not investment advice.